| (S)-nicotine | multiple interactions | ISO | RGD:1313374 | 6480464 | Nicotine inhibits the reaction [RBL1 protein binds to CDC6 promoter]; more ... | CTD | PMID:16862215 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1313374 | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of RBL1 mRNA] | CTD | PMID:11007951 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1313375 | 6480464 | Tetrachlorodibenzodioxin affects the expression of RBL1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1313375 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RBL1 mRNA | CTD | PMID:15667827 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1313374 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RBL1 mRNA | CTD | PMID:11007951 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases expression | ISO | RGD:1313375 | 6480464 | Oxazolone results in increased expression of RBL1 mRNA | CTD | PMID:11379042 |
| 4-hydroxynon-2-enal | increases expression | ISO | RGD:1313375 | 6480464 | 4-hydroxy-2-nonenal results in increased expression of RBL1 mRNA | CTD | PMID:19191707 |
| aflatoxin B1 | decreases expression | ISO | RGD:1313375 | 6480464 | Aflatoxin B1 results in decreased expression of RBL1 mRNA | CTD | PMID:19770486 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1313375 | 6480464 | Tretinoin results in increased expression of RBL1 protein | CTD | PMID:15231690 |
| antimycin A | decreases expression | ISO | RGD:1313375 | 6480464 | Antimycin A results in decreased expression of RBL1 mRNA | CTD | PMID:19304788 |
| atrazine | multiple interactions | ISO | RGD:1313374 | 6480464 | [Atrazine co-treated with Arsenates] results in increased expression of RBL1 mRNA | CTD | PMID:18585445 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1313375 | 6480464 | Benzo(a)pyrene results in decreased expression of RBL1 mRNA | CTD | PMID:19770486 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:1313375 | 6480464 | Mustard Gas results in increased expression of RBL1 mRNA | CTD | PMID:15674843 |
| calcitriol | decreases expression | ISO | RGD:1313374 | 6480464 | Calcitriol results in decreased expression of RBL1 mRNA | CTD | PMID:21592394 |
| calcitriol | multiple interactions | ISO | RGD:1313374 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of RBL1 mRNA | CTD | PMID:21592394 |
| camptothecin | decreases expression | ISO | RGD:1313374 | 6480464 | Camptothecin results in decreased expression of RBL1 protein | CTD | PMID:15585644 |
| chlorpyrifos | decreases expression | ISO | RGD:1313375 | 6480464 | Chlorpyrifos results in decreased expression of RBL1 mRNA | CTD | PMID:20350560 |
| cobalt dichloride | decreases expression | ISO | RGD:1313374 | 6480464 | cobaltous chloride results in decreased expression of RBL1 mRNA | CTD | PMID:19320972 PMID:19376846 |
| copper atom | multiple interactions | ISO | RGD:1313374 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of RBL1 mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:1313374 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of RBL1 mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1313374 | 6480464 | Copper Sulfate results in decreased expression of RBL1 mRNA | CTD | PMID:19549813 |
| cycloheximide | multiple interactions | ISO | RGD:1313374 | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of RBL1 mRNA] | CTD | PMID:11007951 |
| dibutyl phthalate | decreases expression | ISO | RGD:1313375 | 6480464 | Dibutyl Phthalate results in decreased expression of RBL1 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | ISO | RGD:1313375 | 6480464 | Dibutyl Phthalate results in decreased expression of RBL1 mRNA | CTD | PMID:17361019 PMID:21266533 |
| doxorubicin | decreases expression | ISO | RGD:1313374 | 6480464 | Doxorubicin results in decreased expression of RBL1 protein | CTD | PMID:16537896 |
| furan | increases expression | EXP | | 6480464 | furan results in increased expression of RBL1 mRNA | CTD | PMID:22079235 |
| hydralazine | multiple interactions | ISO | RGD:1313374 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of RBL1 mRNA | CTD | PMID:17183730 |
| hydrogen peroxide | multiple interactions | ISO | RGD:1313374 | 6480464 | calyculin A inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of RBL1 protein]; more ... | CTD | PMID:12621062 |
| hydrogen peroxide | decreases phosphorylation | ISO | RGD:1313374 | 6480464 | Hydrogen Peroxide results in decreased phosphorylation of RBL1 protein | CTD | PMID:12621062 |
| lamivudine | multiple interactions | ISO | RGD:1313374 | 6480464 | [Zidovudine co-treated with Lamivudine] results in decreased expression of RBL1 mRNA | CTD | PMID:15784690 |
| lidocaine | affects expression | ISO | RGD:1313375 | 6480464 | Lidocaine affects the expression of RBL1 mRNA | CTD | PMID:18931217 |
| LY294002 | decreases expression | ISO | RGD:1313375 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of RBL1 protein | CTD | PMID:15601625 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:1313375 | 6480464 | Diethylnitrosamine results in increased expression of RBL1 mRNA | CTD | PMID:17854601 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:1313375 | 6480464 | Diethylnitrosamine results in increased expression of RBL1 protein | CTD | PMID:17854601 PMID:19887370 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:1313375 | 6480464 | RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of RBL1 mRNA]; more ... | CTD | PMID:17854601 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:1313375 | 6480464 | Diethylnitrosamine results in increased expression of RBL1 protein | CTD | PMID:19887370 PMID:17854601 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:1313375 | 6480464 | RB1 protein affects the reaction [Diethylnitrosamine results in increased expression of RBL1 protein] | CTD | PMID:19887370 |
| okadaic acid | multiple interactions | ISO | RGD:1313374 | 6480464 | Okadaic Acid inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of RBL1 protein] | CTD | PMID:12621062 |
| paracetamol | increases expression | ISO | RGD:1313374 | 6480464 | Acetaminophen results in increased expression of RBL1 mRNA | CTD | PMID:22230336 |
| phenobarbital | increases expression | ISO | RGD:1313375 | 6480464 | Phenobarbital results in increased expression of RBL1 mRNA | CTD | PMID:19482888 |
| phenobarbital | multiple interactions | ISO | RGD:1313375 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of RBL1 mRNA] | CTD | PMID:19482888 |
| pirinixic acid | multiple interactions | ISO | RGD:1313375 | 6480464 | [pirinixic acid co-treated with PPARA] results in increased expression of RBL1 mRNA | CTD | PMID:20813756 |
| pirinixic acid | increases expression | ISO | RGD:1313375 | 6480464 | pirinixic acid results in increased expression of RBL1 mRNA | CTD | PMID:20813756 PMID:17950772 |
| pirinixic acid | multiple interactions | ISO | RGD:1313375 | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in increased expression of RBL1 mRNA] | CTD | PMID:17950772 |
| pirinixic acid | increases expression | ISO | RGD:1313375 | 6480464 | pirinixic acid results in increased expression of RBL1 mRNA | CTD | PMID:17950772 PMID:20813756 |
| rotenone | decreases expression | ISO | RGD:1313375 | 6480464 | Rotenone results in decreased expression of RBL1 mRNA | CTD | PMID:19304788 |
| silver(1+) nitrate | increases expression | ISO | RGD:1313374 | 6480464 | Silver Nitrate results in increased expression of RBL1 mRNA; more ... | CTD | PMID:22831968 |
| sirolimus | multiple interactions | ISO | RGD:1313374 | 6480464 | [TGFB1 protein co-treated with Sirolimus] inhibits the reaction [[E2F4 protein binds to RBL1 protein] which binds to CDK2 protein] | CTD | PMID:12417722 |
| succimer | multiple interactions | ISO | RGD:1313375 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBL1 mRNA | CTD | PMID:21641980 |
| tamoxifen | increases phosphorylation | ISO | RGD:1313375 | 6480464 | Tamoxifen results in increased phosphorylation of RBL1 protein | CTD | PMID:15642790 |
| testosterone | decreases expression | ISO | RGD:1313374 | 6480464 | Testosterone results in decreased expression of RBL1 mRNA | CTD | PMID:21592394 |
| testosterone | multiple interactions | ISO | RGD:1313374 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of RBL1 mRNA | CTD | PMID:21592394 |
| tetrachloromethane | increases expression | ISO | RGD:1313375 | 6480464 | Carbon Tetrachloride results in increased expression of RBL1 mRNA; more ... | CTD | PMID:19887370 |
| toluene 2,4-diisocyanate | increases expression | ISO | RGD:1313375 | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of RBL1 mRNA | CTD | PMID:11379042 |
| troglitazone | decreases expression | ISO | RGD:1313374 | 6480464 | troglitazone results in decreased expression of RBL1 mRNA | CTD | PMID:19140230 |
| valproic acid | affects expression | ISO | RGD:1313375 | 6480464 | Valproic Acid affects the expression of RBL1 mRNA | CTD | PMID:17963808 |
| valproic acid | multiple interactions | ISO | RGD:1313374 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of RBL1 mRNA | CTD | PMID:17183730 |
| zidovudine | multiple interactions | ISO | RGD:1313374 | 6480464 | [Zidovudine co-treated with Lamivudine] results in decreased expression of RBL1 mRNA | CTD | PMID:15784690 |